For years Advisory Board has been researching how technology and macro-economic forces are shaping clinical decision-making, and recent advances in large language models and AI have the potential to make an impact like we’ve never seen before. In this episode, guest host and Advisory Board life sciences expert Soloman Banjo invites Advisory Board expert Amanda Okaka and Optum’s Senior Vice President of Clinical Innovation Dr. Kevin Larson to discuss the technologies that will change clinical decision-making in the next decade, its implications, and what organizations should be thinking about as they integrate them into clinical workflows.

Links:

How clinicians will use evidence in 2032
5 takeaways from our expert panel on technology's role in the future of clinical decision-making
The future of clinical decision-making at the institutional level

Learn more about Advisory Board’s upcoming webinar on key innovations in cancer care for patients by visiting https://www.advisory.com/resources/events

Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

168: Having the tech isn't enough: the future of clinical decision making

Radio Advisory